FDA Approves Ivantis’ Hydrus Microstent

The FDA gave its approval for California devicemaker Ivantis’ Hydrus microstent, used for treating patients with mild to moderate primary open-angle glaucoma (POAG).

The microstent is roughly the size of an eyelash and is made from a super-elastic, biocompatible alloy that is used in many implants.

It is designed to relieve high intraocular pressure frequently seen in patients with POAG by allowing blocked eye fluid channels to flow freely.